These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 3521000

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI, Tannenbaum GA, Cohen DJ, Appel G, Hardy MA.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract] [Full Text] [Related]

  • 23. Renal transplantation in older patients on peritoneal dialysis.
    Cardella CJ, Harding ME, Abraham G, Robinson C, Oreopoulos D, Uldall PR, Jordan M, Cook G, Struthers N, Honey R.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2022-3. PubMed ID: 2652660
    [No Abstract] [Full Text] [Related]

  • 24. Renal transplantation with cyclosporine in the elderly population.
    Velez RL, Brinker KR, Vergne-Marini PJ, Nesser DA, Long DL, Trevino G, Dickerman RM, Helfrich GB.
    Transplant Proc; 1991 Apr; 23(2):1749-52. PubMed ID: 1905073
    [No Abstract] [Full Text] [Related]

  • 25. Quadruple immunosuppressive therapy for liver transplantation.
    Kalayoglu M, Stratta RJ, Hoffmann RM, Sollinger HW, Belzer FO.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):524-9. PubMed ID: 3279646
    [No Abstract] [Full Text] [Related]

  • 26. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Salvatierra O.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract] [Full Text] [Related]

  • 27. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine.
    Schulak JA, Moritz CE, Hricik DE.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560
    [No Abstract] [Full Text] [Related]

  • 28. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
    Khanuja PS, Toledo-Pereyra LH, Gordon DA, Bandlien KO, Whitten JI.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
    [No Abstract] [Full Text] [Related]

  • 29. Cardiac transplantation in the sixth decade of life.
    Szentpetery S, Thames M, Hanrahan J, Morris J, Lower RR.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2492-4. PubMed ID: 3079089
    [No Abstract] [Full Text] [Related]

  • 30. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
    Büsing M, Hölzer H, Schareck WD, Mellert J, Greger B, Hopt UT, Lauchart W.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1601-3. PubMed ID: 2652521
    [No Abstract] [Full Text] [Related]

  • 31. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM, Callender CO, Dunston GM, Flores J, Walters CS, John D, Yeager C, Bond O, Thompson C, Gear JC.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract] [Full Text] [Related]

  • 32. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
    Cardella CJ, Harding ME, deVeber GA, Honey J, Cook GT.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
    [No Abstract] [Full Text] [Related]

  • 33. Quadruple-drug induction therapy in combined renal and pancreatic transplantation--OKT3 versus ATG.
    Illner WD, Theodorakis J, Abendroth D, Schleibner S, Stangl M, Landgraf R, Land W.
    Transplant Proc; 1990 Aug; 22(4):1586-7. PubMed ID: 2117795
    [No Abstract] [Full Text] [Related]

  • 34. Control of rejection of transplanted organs.
    Keown PA, Stiller CR.
    Adv Intern Med; 1986 Aug; 31():17-46. PubMed ID: 3511616
    [No Abstract] [Full Text] [Related]

  • 35. An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping.
    Stuart FP, Stuart JK, Thistlethwaite JR, Gaber AO, Mayes J.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1959-60. PubMed ID: 3152656
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract] [Full Text] [Related]

  • 38. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
    Nestor ZJ, Rocher LL, Merion RM, Swartz RD, Turcotte JG, Campbell DA.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
    [No Abstract] [Full Text] [Related]

  • 39. Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.
    Schilling M, Schleibner S, Abendroth D, Illner WD, Schneeberger H, Land W.
    Transplant Proc; 1990 Oct; 22(5):2283. PubMed ID: 2219369
    [No Abstract] [Full Text] [Related]

  • 40. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC, Sibley RK, Fryd DS.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.